. 2022 Jan 19;11(2):191. doi: 10.3390/antiox11020191

Table 8.

Effects of gentamycin induced testicular damage and pioglitazone treatment on total antioxidant capacity (TAC), total oxidative stress (TOS) and oxidative stress index (OSI) serum levels.

Group Variable	GI (n = 10)	GII (n = 10)	GIII (n = 10)	GIV (n = 10)	GV (n = 10)
TAC (mM/L)	1.53 ± 0.10 ^bc	0.91 ± 0.05 ^ade	1.13 ± 0.03 ^abe	1.3 ± 0.04 ^b	1.48 ± 0.11 ^b^c
TOS (mM/L)	0.32 ± 0.03 ^bcd	2.19 ± 0.10 ^acde	1.32 ± 0.05 ^abde	1.07 ± 0.02 ^abe	0.33 ± 0.03 ^bcd
OSI	0.22 ± 0.03 ^bcd	2.47 ± 0.15 ^acde	1.17 ± 0.05 ^abde	0.84 ± 0.03 ^abce	0.25 ± 0.04 ^bcd

GI: CTL, normal control, GII: GM, gentamycin induced testicular damage, GIII: PIO 5 pioglitazone treated (5 mg/kg/day), GIV: PIO 10 pioglitazone treated (10 mg/kg/day) and GV: PIO 20 pioglitazone treated (20 mg/kg/day). Values are expressed as mean ± SEM, (^a) compared to control group (GI), (^b) compared to GM treated group (GII), (^c) compared to PIO 5 (GIII) group, (^d) compared to PIO 10 (G IV) group, (^e) compared to PIO 20 (GV) group.